ESC 2021 Heart Failure - Physician's Weekly


Advertisement

ESC 2021 Heart Failure

EMPEROR-Preserved: landmark trial in heart failure research

EMPEROR-Preserved proved to be a landmark trial in heart failure research. It demonstrated a clinically meaningful benefit of 21% reduction in the primary composite outcome as well as positive results in secondary outcomes with...

Loading

Advertisement

For latest news and updates
Email-id is invalid